The table below shows Dyne Therapeutics, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$144.92M
-$105.89M
-$78.54M
-$46.91M
-$50.74M
-$18.39M
Capital expenditure
$221.00K
$981.00K
$191.00K
$230.00K
$1.40M
$9.00K
Investing cash flow
-$2.39M
$1.46M
-$179.84M
$27.06M
-$2.14M
-$128.38M
Dividends paid
-
-
-
DYN operating cash flow (10-K history)
Dyne Therapeutics, Inc. reported operating cash flow of -$403.21M for fiscal year 2025. That is down 37.9% from -$292.37M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$11.83M (FY 2019) to -$403.21M. Figures come from the company's audited annual reports as filed with the SEC.
